Chronic kidney failure
Conditions
Interventions
2:Hemoperfusion combined with hemodialysis
Sponsors
The First Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Signed informed consent; 2. Between the ages of 18 and 70, regardless of gender; 3. Recently don't use immunosuppressants and hormones; 4. The duration of maintenance hemodialysis treatment was =3 months, 2-3 times per week, each time was 4 hours, and the dialysis mode was relatively fixed; 5. An abnormal elevation of parathyroid hormone in maintenance hemodialysis patients (PTH>600 pg/ml); 6. Vascular access is an arteriovenous fistula.
Exclusion criteria
Exclusion criteria: 1. Life expectancy <1 year; 2. Allergic to the irrigation equipment; 3. Hemofiltration patients; 4. Unable to cooperate with doctors to complete the research due to mental illness or other subjective and objective reasons; 5. The patient in pregnancy or lactation; 6. Patients with acute infection, malignant tumor, severe liver disease, cerebrovascular disease, heart failure, and critical illness; 7. Previous history of kidney transplantation; 8. Patients with blood transfusion, hemolysis, other clotting disorders, severe bleeding tendency, and active bleeding within 2 months; 9. Irregular dialysis, poor compliance, and inability to cooperate with researchers; 10. Patients who participated in other clinical trials within 3 months prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| parathyroid hormone;ß2-microglobulin(MG);Creatinine;Blood urea nitrogen; | — |
Countries
China
Contacts
Public ContactLi Qing
The First Affiliated Hospital of Kunming University
Outcome results
None listed